Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation

Eye

Volumn 22, Issue 11, 2008, Pages 1398-1403

  Krohn, J ^a,b   Monge, O R ^a   Skorpen, T N ^a   Mork S J ^a,b   Dahl, O ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Brachytherapy; Enucleation; Incidence; Metastases; Mortality; Posterior uveal melanoma

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CATARACT; CLINICAL FEATURE; ENUCLEATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOVASCULAR GLAUCOMA; NORWAY; OPTIC NERVE DISEASE; RADIATION DOSE; RETINA MACULOPATHY; RETROSPECTIVE STUDY; UVEA MELANOMA; VISUAL ACUITY; VITREOUS HEMORRHAGE; INCIDENCE; MELANOMA; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RADIATION EXPOSURE; TREATMENT OUTCOME; TUMOR RECURRENCE; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; EYE ENUCLEATION; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NORWAY; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEAL NEOPLASMS; VISUAL ACUITY; YOUNG ADULT;

EID: 67649391384     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702911     Document Type: Article

References (29)

1. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110: 962-965.
2. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001; 119: 969-982.
3. Shields JA, Shields CL. Atlas of intraocular tumors. Lippincott Williams & Wilkins: Philadelphia, 1999.
4. UICC, International Union against Cancer. TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours, 3rd ed., 2nd revision. Springer-Verlag: Berlin, 1992.
5. Collaborative Ocular Melanoma Study Group. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study. COMS Report No.21. Arch Ophthalmol 2003; 121: 1163-1171.
6. Astrahan MA, Luxton G, Pu Q, Petrovich Z. Conformal episcleral plaque therapy. Int J Radiat Oncol Biol Phys 1997; 39: 505-519.
7. Knutsen S, Hafslund R, Monge OR, Valen H, Muren LP, Rekstad BL et al. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. Int J Radiat Oncol Biol Phys 2001; 51: 1159-1166.
8. Krohn J, Seland JH, Monge OR, Rekstad BL. Transillumination for accurate placement of radioactive plaques in brachytherapy of choroidal melanoma. Am J Ophthalmol 2001; 132: 418-419.
9. Gündüz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999; 127: 579-589.
10. Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931; 36: 131-142.
11. Puusaari I, Heikkonen J, Kivelä T. Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004; 111: 1768-1777.
12. Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A et al. Plaque radiotherapy for large posterior uveal melanomas (≥8-mm thick) in 354 consecutive patients. Ophthalmology 2002; 109: 1838-1849.
13. Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003; 56: 544-555.
14. Lommatzsch PK, Alberti W, Lommatzsch R, Rohrwacher F. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques. Graefes Arch Clin Exp Ophthalmol 1994; 232: 482-487.
15. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 1999; 106: 1571-1577.
16. Shields CL, Shields JA, Karlsson U, Markoe AM, Brady LW. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Ophthalmology 1989; 96: 919-924.
17. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993; 100: 1547-1554.
18. Packer S, Stoller S, Lesser ML, Mandel FS, Finger PT. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992; 99: 767-773.
19. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 1999; 106: 1579-1587.
20. Karlsson UL, Augsburger JJ, Shields JA, Markoe AM, Brady LW, Woodleigh R. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology 1989; 96: 382-388.
21. Vrabec TR, Augsburger JJ, Gamel JW, Brady LW, Hernandez C, Woodleigh R. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991; 98: 984-988.
22. Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand 1995; 73: 340-344.
23. Cohen VML, Carter MJ, Kemeny A, Radatz M, Rennie IG. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmol Scand 2003; 81: 383-388.
24. Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 2004; 82: 517-525.
25. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977; 95: 63-69.
26. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002; 43: 2579-2583.
27. Isager P, Østerlind A, Engholm G, Heegaard S, Lindegaard J, Overgaard J et al. Uveal and conjunctival malignant melanoma in Denmark, 1943-97: Incidence and validation study. Ophthalmic Epidemiol 2005; 12: 223-232.
28. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110: 956-961.
29. Mork T. Malignant neoplasms of the eye in Norway. Incidence, treatment and prognosis. Acta Ophthalmol (Copenh) 1961; 39: 824-831.